Primary Site >> Liver Cancer
Gene >> FANCD2
| 1. | |||||||||||
| Journal: | Cancer Lett. 2007 Oct 28;256(2):186-95. | ||||||||||
| Title: | FANCD2 depletion sensitizes cancer cells repopulation ability in vitro. | ||||||||||
| Author: | Lyakhovich, Alex|Surralles, Jordi | ||||||||||
| PMID: | 17643815 | ||||||||||
| 2. | |||||||||||
| Journal: | Eur J Cancer. 2008 Jul;44(11):1596-602. | ||||||||||
| Title: | Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint. | ||||||||||
| Author: | Wu, Xiao-Ye|Qian, Jia-Jie|Lin, Yi|Zheng, Ming-Hua | ||||||||||
| PMID: | 18492607 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer. 2010 May 28;9:127. | ||||||||||
| Title: | Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. | ||||||||||
| Author: | Palagyi, Andreas|Neveling, Kornelia|Plinninger, Ursula|Ziesch, Andreas|Targosz, Bianca-Sabrina|Denk, Gerald U|Ochs, Stephanie|Rizzani, Antonia|Meier, Daniel|Thasler, Wolfgang E|Hanenberg, Helmut|De Toni, Enrico N|Bassermann, Florian|Schafer, Claus|Goke, B | ||||||||||
| PMID: | 20509860 | ||||||||||
| 4. | |||||||||||
| Journal: | Arch Toxicol. 2015 Jun;89(6):967-77. | ||||||||||
| Title: | Mechanistic relationships between hepatic genotoxicity and carcinogenicity in male B6C3F1 mice treated with polycyclic aromatic hydrocarbon mixtures. | ||||||||||
| Author: | Phillips, Tracie D|Richardson, Molly|Cheng, Yi-Shing Lisa|He, Lingyu|McDonald, Thomas J|Cizmas, Leslie H|Safe, Stephen H|Donnelly, Kirby C|Wang, Fen|Moorthy, Bhagavatula|Zhou, Guo-Dong | ||||||||||
| PMID: | 24888377 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2016 Jun 7;7(23):33557-70. | ||||||||||
| Title: | beta2-spectrin depletion impairs DNA damage repair. | ||||||||||
| Author: | Horikoshi, Nobuo|Pandita, Raj K|Mujoo, Kalpana|Hambarde, Shashank|Sharma, Dharmendra|Mattoo, Abid R|Chakraborty, Sharmistha|Charaka, Vijaya|Hunt, Clayton R|Pandita, Tej K | ||||||||||
| PMID: | 27248179 | ||||||||||
| 6. | |||||||||||
| Journal: | Anticancer Res. 2017 Mar;37(3):1083-1090. | ||||||||||
| Title: | Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma. | ||||||||||
| Author: | Komatsu, Hisateru|Masuda, Takaaki|Iguchi, Tomohiro|Nambara, Sho|Sato, Kuniaki|Hu, Quingjang|Hirata, Hidenari|Ito, Shuhei|Eguchi, Hidetoshi|Sugimachi, Keishi|Eguchi, Hidetoshi|Doki, Yuichiro|Mori, Masaki|Mimori, Koshi | ||||||||||
| PMID: | 28314268 | ||||||||||
| 7. | |||||||||||
| Journal: | Biol Pharm Bull. 2017 Nov 1;40(11):2005-2009. | ||||||||||
| Title: | Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells. | ||||||||||
| Author: | Oda, Yuichiro|Hidaka, Muneaki|Suzuki, Akito | ||||||||||
| PMID: | 28855448 | ||||||||||